Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2018 Jan 31;18(3):219–224. doi: 10.1016/j.clml.2018.01.005

Table 3.

Factors associated with receipt of no novel therapies

Variables Univariate Analysis OR (95% Confidence Interval) Multivariate Analysis aOR (95% Confidence Interval)
Older age (per year) 1.07 (1.06–1.08) 1.07 (1.06–1.08)
African-American descent 1.36 (1.15–1.62) 1.16 (0.95–1.42)
Other race 0.91 (0.70–1.17) 0.90 (0.68–1.20)
Poor performance indicators 2.37 (2.04–2.76) 1.52 (1.28–1.81)
CCI score (per unit) 1.22 (1.18–1.26) 1.15 (1.10–1.19)
Medicaid 1.42 (1.24–1.63) 1.13 (0.96–1.33)
Year of Diagnosis (per year) 0.89 (0.85–0.93) 0.87 (0.83–0.91)
Per every $10,000 increase in median household income 0.94 (0.91–0.96) 0.97 (0.94–1.00)
Female gender 1.12 (0.98–1.27) 1.03 (0.90–1.19)

OR, odds ratio; aOR, adjusted odds ratio; CCI, Charlson Comorbidity Index.

For race, the white race category was used as the reference level.